The effect of injectable albumin on renal and coagulation system activity

Phase 3

Recruiting

• Conditions: Condition 1: Chronic kidney disease. Condition 2: Coagulapathy.; Chronic kidney disease (CKD); Coagulation defect, unspecified; D68.9

• Registration Number: IRCT20191009045037N1
• Lead Sponsor: Shahre-kord University of Medical Sciences

Brief Summary

Not available

Detailed Description

Not available

Study Timeline

• Results First Posted: 1900-01-01
• Last Update Posted: 17 December 2019

Recruitment & Eligibility

• Status: Recruiting
• Sex: All
• Target Recruitment: 80

Inclusion Criteria

Men and women 18 to 75 years
The risk of anesthesia is 1 or 2 with the division of the American Anesthesia Association
A blood urea of less than 38.5 mg / dl
Have a blood creatinine of less than 1.3 mg / dL
Blood platelets range between 150,000 and 300,000
Patient INR less than 1.2
The patient's consent form must be signed by the patient

Exclusion Criteria

Patient with a history of liver disease
Patient with a history of heart failure
Patient history of kidney disease
Patient with a history of coagulopathy

Study & Design

• Study Type: interventional
• Study Design: Not specified

Primary Outcome Measures

Name	Time	Method
The effect of albumin on renal system activity. Timepoint: Preoperatively and 6, 12 and 24 hours postoperatively. Method of measurement: Calometric.

Secondary Outcome Measures

Name	Time	Method
The effect of albumin on coagulation activity. Timepoint: Preoperatively and 6,12,24 hours postoperatively. Method of measurement: Coagulometer.